Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency

The 5-alpha-reductase type 2 deficiency (5ARD2) is an autosomal recessive condition associated with impairment in the conversion of testosterone to dihydrotestosterone. This condition leads to undervirilisation in 46,XY individuals. To date, there have been more than 100 variations identified in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Nanis S. Marzuki, Firman P. Idris, Hannie D. Kartapradja, Alida R. Harahap, Jose R. L. Batubara
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/7676341
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564804711088128
author Nanis S. Marzuki
Firman P. Idris
Hannie D. Kartapradja
Alida R. Harahap
Jose R. L. Batubara
author_facet Nanis S. Marzuki
Firman P. Idris
Hannie D. Kartapradja
Alida R. Harahap
Jose R. L. Batubara
author_sort Nanis S. Marzuki
collection DOAJ
description The 5-alpha-reductase type 2 deficiency (5ARD2) is an autosomal recessive condition associated with impairment in the conversion of testosterone to dihydrotestosterone. This condition leads to undervirilisation in 46,XY individuals. To date, there have been more than 100 variations identified in the gene responsible for 5ARD2 development (steroid 5-alpha-reductase 2, SRD5A2). However, few studies have examined the molecular characterisation of Indonesian 5ARD2 cases. In the current study, we analysed 37 subjects diagnosed with 46,XY DSD (disorders of sex development) with confirmed variations in the SRD5A2 gene. We examined results from testosterone/dihydrotestosterone (T/DHT) and urinary etiocholanolone/androsterone (Et/An) ratios, as well as from molecular and clinical analyses. Twelve variants in the SRD5A2 gene were identified, and 6 of which were novel, namely, c.34–38delGinsCCAGC, p.Arg50His, p.Tyr136∗, p.Gly191Arg, p.Phe194Ile, and p.Ile253Val variants. Moreover, we determined that 20 individuals contained harmful mutations, while the remaining 17 variants were benign. Those containing harmful mutations exhibited more severe phenotypes with median external genitalia masculinisation scores (EMS) of 3 (1.5–9) and were more likely to be diagnosed at a later age, reared as female, and virilised at pubertal age. In addition, the respective sensitivities for detecting severe 5ARD2 cases using T/DHT (cutoff: 10) and urinary Et/An ratios (cutoff: 0.95) were 85% and 90%, whereas mild cases were only identified with 64.7% and 47.1% sensitivity, respectively. Although we were unable to identify clear correlations between genotypic and phenotypic characteristics in this study, we clearly showed that individuals who were homozygous or compound heterozygous for any of the harmful mutations were more likely to exhibit classic 5ARD2 phenotypes, lower EMS, female assignment at birth, and virilisation during puberty. These results serve to inform the development of improved clinical and molecular 5ARD2 diagnostic approaches, specifically in Indonesian patients.
format Article
id doaj-art-17beddce99ee45b2b94d1e91957b58bd
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-17beddce99ee45b2b94d1e91957b58bd2025-02-03T01:10:06ZengWileyInternational Journal of Endocrinology1687-83371687-83452019-01-01201910.1155/2019/76763417676341Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 DeficiencyNanis S. Marzuki0Firman P. Idris1Hannie D. Kartapradja2Alida R. Harahap3Jose R. L. Batubara4Eijkman Institute for Molecular Biology, Jakarta 10430, IndonesiaEijkman Institute for Molecular Biology, Jakarta 10430, IndonesiaEijkman Institute for Molecular Biology, Jakarta 10430, IndonesiaEijkman Institute for Molecular Biology, Jakarta 10430, IndonesiaDoctoral Program in Medicine, Universitas Indonesia, Jakarta 10430, IndonesiaThe 5-alpha-reductase type 2 deficiency (5ARD2) is an autosomal recessive condition associated with impairment in the conversion of testosterone to dihydrotestosterone. This condition leads to undervirilisation in 46,XY individuals. To date, there have been more than 100 variations identified in the gene responsible for 5ARD2 development (steroid 5-alpha-reductase 2, SRD5A2). However, few studies have examined the molecular characterisation of Indonesian 5ARD2 cases. In the current study, we analysed 37 subjects diagnosed with 46,XY DSD (disorders of sex development) with confirmed variations in the SRD5A2 gene. We examined results from testosterone/dihydrotestosterone (T/DHT) and urinary etiocholanolone/androsterone (Et/An) ratios, as well as from molecular and clinical analyses. Twelve variants in the SRD5A2 gene were identified, and 6 of which were novel, namely, c.34–38delGinsCCAGC, p.Arg50His, p.Tyr136∗, p.Gly191Arg, p.Phe194Ile, and p.Ile253Val variants. Moreover, we determined that 20 individuals contained harmful mutations, while the remaining 17 variants were benign. Those containing harmful mutations exhibited more severe phenotypes with median external genitalia masculinisation scores (EMS) of 3 (1.5–9) and were more likely to be diagnosed at a later age, reared as female, and virilised at pubertal age. In addition, the respective sensitivities for detecting severe 5ARD2 cases using T/DHT (cutoff: 10) and urinary Et/An ratios (cutoff: 0.95) were 85% and 90%, whereas mild cases were only identified with 64.7% and 47.1% sensitivity, respectively. Although we were unable to identify clear correlations between genotypic and phenotypic characteristics in this study, we clearly showed that individuals who were homozygous or compound heterozygous for any of the harmful mutations were more likely to exhibit classic 5ARD2 phenotypes, lower EMS, female assignment at birth, and virilisation during puberty. These results serve to inform the development of improved clinical and molecular 5ARD2 diagnostic approaches, specifically in Indonesian patients.http://dx.doi.org/10.1155/2019/7676341
spellingShingle Nanis S. Marzuki
Firman P. Idris
Hannie D. Kartapradja
Alida R. Harahap
Jose R. L. Batubara
Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
International Journal of Endocrinology
title Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
title_full Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
title_fullStr Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
title_full_unstemmed Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
title_short Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
title_sort characterising srd5a2 gene variants in 37 indonesian patients with 5 alpha reductase type 2 deficiency
url http://dx.doi.org/10.1155/2019/7676341
work_keys_str_mv AT nanissmarzuki characterisingsrd5a2genevariantsin37indonesianpatientswith5alphareductasetype2deficiency
AT firmanpidris characterisingsrd5a2genevariantsin37indonesianpatientswith5alphareductasetype2deficiency
AT hanniedkartapradja characterisingsrd5a2genevariantsin37indonesianpatientswith5alphareductasetype2deficiency
AT alidarharahap characterisingsrd5a2genevariantsin37indonesianpatientswith5alphareductasetype2deficiency
AT joserlbatubara characterisingsrd5a2genevariantsin37indonesianpatientswith5alphareductasetype2deficiency